oRNA Platform engineers circular RNA with lipid nanoparticles for genetic medicines and in vivo cell therapies.
oRNA Platform is built around fully engineered circular RNA therapeutics paired with lipid nanoparticle delivery. The platform is designed to let a patient's body generate therapeutic proteins and cell therapies, including in vivo immune-cell engineering programs.
The platform combines circular RNA design, formulation into lipid nanoparticles, and development programs for genetic medicine. Its integrated approach connects engineered RNA payloads, nonviral delivery, and therapeutic development for biopharma programs.
| Attribute | oRNA Platform | Strand Signal Stack | |
|---|---|---|---|
| Provider | |  | |
| Founded | 2019 | 2017 | |
| Sells To | Consumers | Enterprise | |
| Pricing Model | — | Licensing | |
| Ownership | Private, Venture-backed | Venture-backed |
Provider
Founded 2019
Sells To Consumers
Pricing Model —
Ownership Private, Venture-backed
Provider
Founded 2017
Sells To Enterprise
Pricing Model Licensing
Ownership Venture-backed
A programmable RNA editing platform developing therapies for genetic disease.
An engineered transfer RNA platform that suppresses premature stop codons to restore protein translation.
Selective organ-targeting lipid nanoparticle platform for genetic medicine delivery beyond the liver.
STARR combines self-replicating RNA with LUNAR lipid-mediated delivery for therapeutic protein expression.
Aptamer delivery platform for tissue-specific delivery of RNA payloads including siRNA, ASO, and LNPs.
Korro Bio's OPERA platform uses engineered oligonucleotides to make precise RNA edits, co-opting endogenous ADAR to correct disease-causing transcripts.
Clinically validated lipid nanoparticle delivery systems for nucleic acid therapeutics.
A programmable RNA editing platform developing therapies for genetic disease.
An engineered transfer RNA platform that suppresses premature stop codons to restore protein translation.
Selective organ-targeting lipid nanoparticle platform for genetic medicine delivery beyond the liver.
STARR combines self-replicating RNA with LUNAR lipid-mediated delivery for therapeutic protein expression.
Aptamer delivery platform for tissue-specific delivery of RNA payloads including siRNA, ASO, and LNPs.
Korro Bio's OPERA platform uses engineered oligonucleotides to make precise RNA edits, co-opting endogenous ADAR to correct disease-causing transcripts.
Clinically validated lipid nanoparticle delivery systems for nucleic acid therapeutics.